⌘K

D

DCVC

Crunchbase
Pitchbook
Crunchbase

Deals on record

26

Common Fundraising Type

Series A

A
AIM

Embodied AI • Earthmoving Machinery

Khosla Ventures logo
Ironspring Ventures logo
Human Capital logo
General Catalyst logo

AIM develops an embodied AI platform that retrofits existing earthmoving machinery to enhance safety and productivity in the construction and mining industries.

Equity
$50M
06/19/2025
Article
I
Impulse Space

In-space transportation • Helios vehicles

Valor Equity Partners logo
Trousdale Ventures logo
Tamarack Global logo
Spring Tide logo

Impulse Space provides in-space transportation services and is developing the Helios and Mira vehicles to support various space missions.

Series C
$300M
06/03/2025
Article
A
Alta Resource Technologies

Rare earth elements • E-waste

Voyager Ventures logo
Orion Industrial Ventures logo
In-Q-Tel logo
DCVC logo

Alta Resource Technologies develops a protein-based method to extract rare earth elements from e-waste, aiming to produce these metals domestically and enhance national security.

Seed
$4.4M
05/05/2025
Article
G
Grove Biopharm

Biotechnology • Bionic Biologics

Walder Ventures logo
Portal Innovations logo
Mansueto Investments logo
InVivium Capital logo

Grove Biopharma is a biotechnology company developing a platform for creating novel therapies targeting intracellular protein-protein interactions, particularly for oncology applications.

Series A
$30M
04/24/2025
Article
M
Mainspring

Linear generators • Power solutions

Temasek logo
Pictet Group logo
Marunouchi Innovation Partners logo
M&G Investments logo

Mainspring develops and manufactures linear generators that provide cost-effective, reliable, and flexible power solutions capable of using multiple fuels and scalable from 250 kW to over 100 MW.

Series F
$258M
04/15/2025
Article
S
Solu Therapeutics

Cancer • Immunology

The Leukemia & Lymphoma Society logo
Sant logo
Pappas Capital logo
Longwood Fund logo

Solu Therapeutics develops therapies to selectively eliminate disease-driving cells in cancer and immunology, focusing on conditions like chronic myelomonocytic leukemia.

Series A
$41M
04/09/2025
Article
L
Lumafield

Industrial X-ray CT • Product development

Wellington Management logo
Spark Capital logo
Matter Venture Partners logo
Lux Capital logo

Lumafield provides industrial X-ray CT technology solutions to enhance product development and manufacturing processes.

Series C
$75M
03/14/2025
Article
N
Newleos Therapeutics

Neuroscience • Clinical-stage

Novo Holdings logo
Longwood Fund logo
Goldman Sachs Alternatives logo
DCVC Bio logo

Newleos Therapeutics is a clinical-stage neuroscience company developing therapies for neuropsychiatric disorders, including anxiety and cognitive impairments, with a focus on first-in-class and best-in-class treatments.

Series A
$93.5M
02/13/2025
Article
U
Umoja Biopharma

Biotechnology • In vivo cell therapies

University of Minnesota Endowment logo
SoftBank logo
RTW Investments logo
Qiming Venture Partners USA logo

Umoja Biopharma is a biotechnology company focused on developing in vivo CAR T cell therapies for oncology and autoimmune diseases using its VivoVecâ„¢ gene delivery technology.

Series C
$100M
01/20/2025
Article
A
Alta Resource

Rare earth elements • E-waste

WovenEarth Ventures logo
Voyager Ventures logo
Overture logo
Orion Industrial Ventures logo

Alta Resource Technologies develops a protein-based method to extract rare earth elements from e-waste, aiming to produce these metals domestically and enhance national security.

Seed
$6.1M
01/07/2025
Article
F
Fervo Energy

Enhanced geothermal systems • Power development

Mercuria logo
Sabanci Climate Ventures logo
Liberty Mutual Investments logo
Galvanize Climate Solutions logo

Fervo Energy develops enhanced geothermal systems to provide 24/7 carbon-free energy.

Hybrid
$255M
12/19/2024
Article
S
Slip Robotics

Automated • Truck-loading

DCVC logo
Tech Square Ventures logo
Pathbreaker Ventures logo
Overline logo

Slip Robotics develops automated robots that can load and unload trucks in just 5 minutes, enhancing efficiency and safety in logistics operations.

Series B
$28M
12/17/2024
Article
n
nChroma Bio

Epigenetic editing • Genetic medicines

Wilson Sonsini Goodrich & Rosati logo
Wellington Management logo
T. Rowe Price logo
Sofinnova Partners logo

nChroma Bio develops innovative genetic medicines using epigenetic editing and non-viral delivery technologies to treat chronic hepatitis B and D.

Equity
$75M
12/11/2024
Article
R
Radiant

Advanced nuclear technology • Microreactor

Washington Harbour Partners logo
Union Square Ventures logo
McKinley Alaska logo
Founders Fund logo

Radiant Industries develops advanced nuclear microreactors to provide reliable, low-carbon energy solutions for remote locations and industries.

Series C
$100M
11/15/2024
Article
Z
Zap Energy

Fusion • Technology

Zap Energy is developing a unique fusion technology to generate electricity by compressing plasma with an electric current, eliminating the need for expensive magnets or lasers.

Series D
$130M
10/16/2024
Article
E
Equilibrium Energy

Clean power technology • Battery management

Valo Ventures logo
DCVC logo
Breakthrough Energy Ventures logo

Equilibrium Energy specializes in clean power technology, focusing on battery management and grid-scale energy solutions.

Series B
$39M
10/15/2024
Article
I
Impulse Space

In-space transportation • Helios vehicles

Founders Fund logo
Tamarack Global logo
Trousdale Ventures logo
Spring Tide logo

Impulse Space provides in-space transportation services and is developing the Helios and Mira vehicles to support various space missions.

Series B
$150M
10/01/2024
Article
T
Tidal Metals

Magnesium production • Seawater extraction

First Spark Ventures logo
DCVC logo
Bidra Innovation Ventures logo

Tidal Metals extracts magnesium from seawater and desalination brine using a temperature-swing vapor pump process, aiming to provide a less polluting alternative to traditional magnesium production methods.

Seed
$8.5M
09/19/2024
Article
N
Noetik

AI • Biotech

Polaris Partners logo
Zetta Venture Partners logo
Wittington Ventures logo
North South Ventures logo

Noetik is an AI-native biotech company that leverages spatial omics data and high-throughput CRISPR technology to develop precision oncology therapies.

Series A
$40M
08/29/2024
Article
T
Totus Medicines

Drug Discovery • Small Molecule

Regents of the University of Minnesota logo
North Pond Ventures logo
DCVC Bio logo
Camford Capital logo

Totus Medicines is a biotech company specializing in the discovery of novel small molecule drugs through the use of covalent libraries and artificial intelligence, focusing on diseases previously considered undruggable.

Series B
$66M
12/15/2023
Article
F
Fourth Power

Thermal Battery Solutions • Renewable Energy Storage

DCVC logo
Breakthrough Energy Ventures logo
Black Venture Capital Consortium logo

Fourth Power is a company that develops utility-scale thermal battery technology to store renewable energy using a system that heats liquid tin and carbon blocks, enabling efficient and scalable grid decarbonization with rapid energy dispatch capabilities.

Series A
$19M
12/12/2023
Article
R
Reality Defender

Deepfakes • AI-generated content

AI Grant logo
Parameter Ventures logo
Ex/ante logo
DCVC logo

Reality Defender is a startup that specializes in detecting deepfakes and AI-generated content, and has raised $15 million in a Series A funding round to expand its team and improve its AI content detection models.

Series A
$15M
10/17/2023
Article
M
Mach Industries

Defense Technology • Hydrogen-Powered Platforms

Marque logo
DCVC logo
Bedrock Capital logo

Mach Industries is a defense startup that develops hydrogen-powered platforms and munitions for the military, focusing on unmanned aerial vehicles and hydrogen generation systems.

Series A
$79M
10/04/2023
Article
N
Noetik

AI • Biotech

Zetta Venture Partners logo
DCVC logo
North South Ventures logo
Intermountain Ventures logo

Noetik is an AI-native biotech company that leverages spatial omics data and high-throughput CRISPR technology to develop precision oncology therapies.

Seed
$14M
09/07/2023
Article
C
CH4 Global

Climate Tech • Aquaculture

DCVC Bio logo
Cleveland Avenue logo

CH4 Global is a climate tech company that produces a feed additive for cattle, using Asparagopsis seaweed, to reduce greenhouse gas emissions by up to 90% in the food industry value chain.

Series B
$29M
08/29/2023
Article
C
CH4 Global

Climate Tech • Aquaculture

DCVC Bio logo
Cleveland Avenue logo

CH4 Global is a climate tech company that produces a feed additive for cattle, using Asparagopsis seaweed, to reduce greenhouse gas emissions by up to 90% in the food industry value chain.

Series B
$29M
08/29/2023
Article